Abstract
Cell therapy using mesenchymal stem cells (MSCs) is a promising strategy to treat large bone defects and the study of molecules that act on these cells to favor bone regeneration is essential in this context. Our research group have demonstrated that the extracellular matrix protein agrin participates in osteoblastic differentiation, probably by regulating BMP and Wnt signaling pathways, …